IMF Bentham Ltd. engages in the investigation, management and funding of litigation and arbitration claims. Its services include factual investigations preliminary to litigation; appeal funding; payment of adverse costs orders, strategic planning, monitoring, and managing of litigation; and assistance in facilitating settlements and and maximizing the value of each claim. The company was founded in 2001 and is headquartered in Sydney, Australia.
Company profile
Ticker
IMM
Exchange
Website
CEO
Andrew Saker
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Immune Network Research LTD
SEC CIK
IRS number
891078933
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
17 Jan 13
6-K
6-K Dated March 10, 2003
11 Mar 03
6-K
Form 6-K for Sept 10/02 News Release
11 Sep 02
6-K
Form 6-K for Quarter Ended June 30, 2002
5 Sep 02
6-K
Immune Form 6-K for August 6 NR
22 Aug 02
6-K
News Release and Form 53-901F for July 26, 2002
30 Jul 02
20-F
2001 FY
Annual report (foreign)
16 Jul 02
6-K
News Release, Form 53-901F and Agm
9 Jul 02
NT 20-F
Notice of late annual filing (foreign)
28 Jun 02
6-K
May 22, 2002
24 May 02
Latest ownership filings
No filings